These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8692788)
41. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. Rockwood K; Fay S; Gorman M Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273 [TBL] [Abstract][Full Text] [Related]
42. The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients. Talwalker S J Biopharm Stat; 1996 Nov; 6(4):443-56. PubMed ID: 8969979 [TBL] [Abstract][Full Text] [Related]
43. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease. Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865 [TBL] [Abstract][Full Text] [Related]
44. [Assessment and treatment of patients with dementia of the Alzheimer type]. Homma A Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):264-70. PubMed ID: 1614005 [TBL] [Abstract][Full Text] [Related]
45. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ; Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448 [TBL] [Abstract][Full Text] [Related]
46. [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia]. Krzymińska E; Rossa G; Krzymiński S Psychiatr Pol; 1993; 27(2):129-38. PubMed ID: 8378466 [TBL] [Abstract][Full Text] [Related]
47. [Clinical heterogeneity of dementia of the Alzheimer type]. Gavrilova SI; Korsakova NK; Vavilov SB; Selezneva ND; Kalyn IaB; Dybovskaia NR; Roshchina IF; Medvedev LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):44-50. PubMed ID: 2176041 [TBL] [Abstract][Full Text] [Related]
48. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach. Posner HB; Cano S; Carrillo MC; Selnes O; Stern Y; Thomas RG; Zajicek J; Hobart J; Alzheimers Dement; 2013 Feb; 9(1 Suppl):S56-60. PubMed ID: 23391006 [TBL] [Abstract][Full Text] [Related]
49. Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K). Youn JC; Lee DY; Kim KW; Lee JH; Jhoo JH; Lee KU; Ha J; Woo JI Int J Geriatr Psychiatry; 2002 Sep; 17(9):797-803. PubMed ID: 12221651 [TBL] [Abstract][Full Text] [Related]
50. [Mild cognitive impairment: a prodromal phase of dementia?]. Jonker C; Comijs HC Tijdschr Gerontol Geriatr; 2007 Jul; 38(3):115-21. PubMed ID: 17642317 [TBL] [Abstract][Full Text] [Related]
51. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. Pomara N; Ott BR; Peskind E; Resnick EM Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274 [TBL] [Abstract][Full Text] [Related]
52. Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Llano DA; Laforet G; Devanarayan V; Alzheimer Dis Assoc Disord; 2011; 25(1):73-84. PubMed ID: 20847637 [TBL] [Abstract][Full Text] [Related]
53. [Vascular factors and the psychopathological picture in Alzheimer's disease]. Idzan LB; Bidzan M Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228 [TBL] [Abstract][Full Text] [Related]
54. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Reisberg B; Gauthier S Int Psychogeriatr; 2008 Feb; 20(1):1-16. PubMed ID: 18072981 [No Abstract] [Full Text] [Related]
55. Cognitive deficits of mild dementia: A comparison between dementia of the Alzheimer's type and vascular dementia. Matsuda O; Saito M; Sugishita M Psychiatry Clin Neurosci; 1998 Feb; 52(1):87-91. PubMed ID: 9682939 [TBL] [Abstract][Full Text] [Related]
56. [Early Mental Test--developing a screening test for mild cognitive impairment]. Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229 [TBL] [Abstract][Full Text] [Related]
57. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia]. Bidzan M; Bidzan L Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769 [TBL] [Abstract][Full Text] [Related]
58. Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. Carpenter BD; Xiong C; Porensky EK; Lee MM; Brown PJ; Coats M; Johnson D; Morris JC J Am Geriatr Soc; 2008 Mar; 56(3):405-12. PubMed ID: 18194228 [TBL] [Abstract][Full Text] [Related]
59. [Mini-Mental State Examination:a useful method for the evaluation of the cognitive status of patients by the clinician. Consensual French version]. Derouesne C; Poitreneau J; Hugonot L; Kalafat M; Dubois B; Laurent B Presse Med; 1999 Jun; 28(21):1141-8. PubMed ID: 10399508 [TBL] [Abstract][Full Text] [Related]
60. Correlations between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale when administered to patients with dementia residing in long-term care. Tsolaki M; Alexiadou A; Kiosseoglou G; Kounti F Am J Alzheimers Dis Other Demen; 2006; 21(4):274-80. PubMed ID: 16948292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]